Brief: Valeo Pharma Reports Record Quarterly And Annual Revenues For Q4 And The Fiscal Year 2022
30/01/2023 21:55
Jan 30 (Reuters) - Valeo Pharma Inc VPH.TO :
* VALEO PHARMA REPORTS RECORD QUARTERLY AND ANNUAL REVENUES
FOR
THE FOURTH QUARTER AND THE FISCAL YEAR 2022
* VALEO PHARMA INC Q4 REVENUE ROSE 274 PERCENT TO C$12.7
MILLION
* VALEO PHARMA INC - NET LOSS WAS $9.3 MILLION FOR QUARTER
ENDED
OCTOBER 31, 2022 COMPARED TO $7.7 MILLION FOR QUARTER ENDED
OCTOBER 31, 2021
Source text for Eikon: ID:nCNWBzTb3a
Further company coverage: VPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada